Neoadjuvant chemotherapy: A new criterion for selection of candidate patients for surgery of low tumour burden metastases from malignant melanoma?

British Journal of Dermatology

Volumn 163, Issue 1, 2010, Pages 183-187

  Jouary, T ^a   Legros, C ^a   Lalanne, N ^a   Versapuech, J ^a   Ezzedine, K ^a   Vergier, B ^b   Delaunay, M ^a   Velly, J F ^b   Taieb, A ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

melanoma; metastasis; metastatic surgery; neoadjuvant chemotherapy; overall survival; prognosis criteria

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; DACARBAZINE; TEMOZOLOMIDE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DRUG RESPONSE; FEMALE; HUMAN; LUNG LOBECTOMY; LUNG METASTASIS; MALE; MEDICAL RECORD REVIEW; MELANOMA; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THORAX SURGERY;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOADJUVANT THERAPY; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77953992444     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09736.x     Document Type: Article

References (17)

1. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007 18 : 581 592.
2. Hoey SHE, Devereux CEJ, Murray L et al. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. Br J Dermatol 2007 156 : 1301 1307.
3. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002 146 (Suppl. 61 S1 6.
4. Essner R, Lee JH, Wanek LA et al. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 2004 139 : 961 967.
5. Petersen RP, Hanish SI, Haney JC et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. Gen Thorac Cardiovasc Surg 2007 133 : 104 110.
6. Ollila DW, Hsueh EC, Stern SL, Morton DL. Metastasectomy for recurrent stage IV melanoma. J Surg Oncol 1999 71 : 209 213.
7. Harpole DH, Johnson CM, Wolfe WG et al. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 1992 103 : 743 750.
8. Pastorino U, Buyse M, Friedel G et al. Long term results of pulmonary metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997 113 : 37 49.
9. Andrews S, Robinson L, Cantor A, DeConti RC. Survival after surgical resection of isolated pulmonary metastases from malignant melanoma. Cancer Control 2006 13 : 218 223.
10. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000 92 : 205 216.
11. Chapman PB, Einhorn LH, Meyers ML et al. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999 17 : 2745 2751.
12. Avril MF, Aamdal S, Grob JJ et al. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol 2004 22 : 1118 1125.
13. Keilholz U, Punt CJ, Gore M et al. Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organization for Research and Treatment of Cancer Melanoma Group. J Clin Oncol 2005 23 : 6747 6755.
14. Ives NJ, Stowe RL, Lorigan P, Wheatley K. Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients. J Clin Oncol 2007 25 : 5426 5434.
15. Delaunay MM, Amici JM, Avril MF et al. Chirurgie des métastases pulmonaires du mélanome malin. Ann Dermatol Venereol 1991 118 : 287 295.
16. Flaherty KT, Schiller J, Schuchter LM et al. A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplain and paclitaxel. Clin Cancer Res 2008 14 : 4836 4842.
17. Khayat D, Borel C, Tourani JM et al. Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma. J Clin Oncol 1993 11 : 2173 2180.